{
    "2021-07-12": [
        [
            {
                "time": "",
                "original_text": "天坛生物：吴永林因个人原因辞去公司董事职务 董监高成员变化",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "吴永林",
                        "辞职",
                        "董事"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：吴永林辞去董事职务 董监高成员变化",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "吴永林",
                        "辞职",
                        "董事"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：董事辞职 董监高成员变化",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "董事",
                        "辞职"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业一周观察：板块大幅调整 如何看待创新药和CXO的未来",
                "features": {
                    "keywords": [
                        "医药行业",
                        "板块调整",
                        "创新药",
                        "CXO"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：十四五开启血制品新成长周期 重点推荐天坛生物、博雅生物等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "十四五",
                        "血制品",
                        "天坛生物",
                        "博雅生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}